Leilei Fu
Impact in
- Geriatrics and Gerontology top 1%
- Sirtuins and Resveratrol in Medicine
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Epidemiology 27
- Autophagy in Disease and Therapy 21
- Hepatitis B Virus Studies 5
Leilei Fu
56 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Geriatrics and Gerontology 227
- Cancer Research 543
- Physiology 155
- Molecular Biology 1.7k
- Epidemiology 821
Countries citing papers authored by Leilei Fu
This map shows the geographic impact of Leilei Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leilei Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leilei Fu more than expected).
Fields of papers citing papers by Leilei Fu
This network shows the impact of papers produced by Leilei Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leilei Fu. The network helps show where Leilei Fu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Leilei Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 37 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 37 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 49 | |
| 13 | 2019 | 11 | |
| 14 | 2018 | 87 | |
| 15 | 2016 | 16 | |
| 16 | 2016 | 23 | |
| 17 | 2016 | 75 | |
| 18 | 2015 | 30 | |
| 19 | 2013 | 172 | |
| 20 | 2012 | 15 |
About Leilei Fu
Leilei Fu is a scholar working on Geriatrics and Gerontology, Epidemiology, Physiology, Computational Theory and Mathematics and Oncology, having authored 59 papers that have together received 2.8k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (21 papers), Computational Drug Discovery Methods (9 papers), Ubiquitin and proteasome pathways (7 papers), Protein Degradation and Inhibitors (6 papers), MicroRNA in disease regulation (5 papers), Melanoma and MAPK Pathways (5 papers), Hepatitis B Virus Studies (5 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Geriatrics and Gerontology (227 citations), Cancer Research (543 citations), Physiology (155 citations), Molecular Biology (1.7k citations) and Epidemiology (821 citations). Leilei Fu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Bo Liu, Liang Ouyang, Lan Zhang, Yi Chen, Xin Wen, Cheng Peng, Minru Liao, Peng Fu, Bo Han and Rui Qin. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, Cell Proliferation, Oncotarget and APOPTOSIS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.